SCHEMBL22680429

SCHEMBL22680429

CCC1(C)C=Cc2nccnc2N=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22679955 0.77 — —
SCHEMBL22679766 0.77 — —
SCHEMBL22679954 0.71 — —
SCHEMBL20074493 0.62 — —
SCHEMBL22281355 0.61 — —
SCHEMBL21131993 0.61 — —
SCHEMBL22680419 0.56 — —
SCHEMBL28305777 0.56 — —
SCHEMBL26492373 0.55 — —
SCHEMBL22591415 0.54 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020231739-A2 COMPOUNDS AND METHODS FOR TREATING CANCER ANTIDOTE IP HOLDINGS, LLC (US) 2020-11-19 — — WO disclosed
Send feedback